You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Corneal Endothelial Cell Loss

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B, Healthy Trial in United Kingdom (ChAdOx1-HBV)

Completed
  • Hepatitis B
  • Healthy
  • ChAdOx1-HBV
  • Southampton, Hampshire, United Kingdom
  • +3 more
Jul 22, 2022

Asthenozoospermia, Oligospermia Trial in Catania (Myo-inositol normospermic, Myo-inositol OAT, Folic Acid normospermic)

Completed
  • Asthenozoospermia
  • Oligospermia
  • Myo-inositol normospermic
  • +2 more
  • Catania, CT, Italy
    Centre of Physiopathology of Reproduction
Jul 20, 2022

Non-hodgkin Lymphoma,B Cell Trial in Shenzhen (Allogeneic CD19 CR-T cell)

Recruiting
  • Non-hodgkin Lymphoma,B Cell
  • Allogeneic CD19 CR-T cell
  • Shenzhen, Guangdong, China
    Li Yu
Nov 22, 2021

Mantle Cell Lymphoma Trial in Tianjin (Orelabrutinib in in combination of rituximab and lenalidomide(OLR))

Recruiting
  • Mantle Cell Lymphoma
  • Orelabrutinib in in combination of rituximab and lenalidomide(OLR)
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Insititute & Hospital
Nov 3, 2021

Asthma, COPD Trial in London, Manchester (SelK2 (Part 1), Placebo (Part 1), SelK2 (Part 2))

Completed
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • SelK2 (Part 1)
  • +3 more
  • London, United Kingdom
  • +1 more
Feb 1, 2022

CCND1 Gene Amplification, CCND2 Gene Amplification, CCND3 Gene Amplification Trial in United States (Docetaxel, Laboratory

Completed
Has Results
  • CCND1 Gene Amplification
  • +5 more
  • Birmingham, Alabama
  • +1064 more
May 25, 2021

Sodium MRI for Tumour Characterisation and Assessment of Therapy

Recruiting
  • Breast Cancer
  • MRI
  • PET/MRI
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Feb 24, 2022

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC

Recruiting
  • Cancer
  • Blood draw and blood-based biomarkers analyses
  • Shanghai, Shanghai, China
    ZhongShan hospital FuDan university
Feb 10, 2022

Colorectal Cancer Trial in Koege (Influenza vaccine, Pembrolizumab)

Not yet recruiting
  • Colorectal Cancer
  • Koege, Zealand, Denmark
    Center for Surgical Science, Department of Surgery, Zealand Univ
Jun 9, 2023

Recurrent Fallopian Tube Clear Cell Adenocarcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Platinum-Resistant

Recruiting
  • Recurrent Fallopian Tube Clear Cell Adenocarcinoma
  • +5 more
  • Etigilimab
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 22, 2021

Priapism Trial in United States (crizanlizumab)

Recruiting
  • Priapism
  • Birmingham, Alabama
  • +18 more
Jan 17, 2023

Diabete Type 2, Obesity Trial (Endoscopic sutured gastroplasty with endomina)

Not yet recruiting
  • Diabete Type 2
  • Obesity
  • Endoscopic sutured gastroplasty with endomina
  • (no location specified)
Oct 26, 2022

Esophageal Small Cell Carcinoma Trial in Guangzhou (JS001, nab-paclitaxel, Cisplatin)

Recruiting
  • Esophageal Small Cell Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 27, 2021

Metastatic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Intensity-modulated radiotherapy concurrent with capecitabine)

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Intensity-modulated radiotherapy concurrent with capecitabine
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer center
Aug 21, 2022

HIV Trial in Baltimore (Lopinavir/Ritonavir)

Terminated
Has Results
  • HIV
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Jan 20, 2022

High-Normal Blood Pressure Trial in Bologna (Dietary Supplement, Placebo)

Recruiting
  • High-Normal Blood Pressure
  • Dietary Supplement
  • Placebo
  • Bologna, Italy
    S. Orsola-Malpighi University Hospital
Dec 9, 2021

Multiple Myeloma Trial in New York (EGFRt/BCMA-41BBz CAR T cell, Cyclophosphamide, Lenalidomide.)

Active, not recruiting
  • Multiple Myeloma
  • EGFRt/BCMA-41BBz CAR T cell
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 7, 2022

the Type ONe dIabetic Bone Collaboration Study

Recruiting
  • Osteoporosis Secondary
  • Diabetes Mellitus, Type 1
    • Aalborg, Denmark
      Steno Diabetes Center Nordjylland
    Dec 30, 2022

    Fibrodysplasia Ossificans Progressiva Trial in Worldwide (IPN60130, Placebo)

    Recruiting
    • Fibrodysplasia Ossificans Progressiva
    • San Francisco, California
    • +18 more
    Aug 18, 2022

    Colorectal Tumors Trial in New York (Botensilimab, Balstilimab)

    Not yet recruiting
    • Colorectal Neoplasms
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jan 24, 2023

    Genetic Factors of Desmopressin Response in Carriers of

    Completed
    • Carrier of Hemophilia A
    • +2 more
    • Bordeaux, France
    • +11 more
    Aug 28, 2023

    Age-Related Atrophy Trial in Boca Raton, Nashville, Dallas (AAM)

    Completed
    • Age-Related Atrophy
    • AAM
    • Boca Raton, Florida
    • +2 more
    May 7, 2021

    Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +2 more
    • Panitumumab
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Feb 16, 2023

    Sickle Cell Anemia, Sickle Cell-Beta0-Thalassemia Trial in Chapel Hill (rivaroxaban, )

    Completed
    Has Results
    • Sickle Cell Anemia
    • Sickle Cell-Beta0-Thalassemia
    • Chapel Hill, North Carolina
      University of North Carolina - Chapel Hill
    Apr 9, 2020

    Advanced NSCLC Trial in Guangzhou (Surufatinib, Surufatinib Plus Vinorelbine)

    Recruiting
    • Advanced Non-Small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Affiliated Cancer Hospital and Institute of Guangzhou Medical Un
    Aug 18, 2022